Cargando…
Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema
PURPOSE: Retinal function beyond foveal vision is not routinely examined in the clinical screening and management of diabetic retinopathy although growing evidence suggests it may precede structural changes. In this study we compare optical coherence tomography (OCT) based macular structure with fun...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270604/ https://www.ncbi.nlm.nih.gov/pubmed/37319294 http://dx.doi.org/10.1371/journal.pone.0287319 |
_version_ | 1785059349434990592 |
---|---|
author | Sabeti, Faran Rai, Bhim B. van Kleef, Josh P. Rohan, Emilie M. F. Carle, Corinne F. Barry, Richard C. Essex, Rohan W. Nolan, Christopher J. Maddess, Ted |
author_facet | Sabeti, Faran Rai, Bhim B. van Kleef, Josh P. Rohan, Emilie M. F. Carle, Corinne F. Barry, Richard C. Essex, Rohan W. Nolan, Christopher J. Maddess, Ted |
author_sort | Sabeti, Faran |
collection | PubMed |
description | PURPOSE: Retinal function beyond foveal vision is not routinely examined in the clinical screening and management of diabetic retinopathy although growing evidence suggests it may precede structural changes. In this study we compare optical coherence tomography (OCT) based macular structure with function measured objectively with the ObjectiveFIELD Analyzer (OFA), and with Matrix perimetry. We did that longitudinally in Type 2 diabetes (T2D) patients with mild Diabetic Macular Oedema (DMO) with good vision and a similar number of T2D patients without DMO, to evaluate changes in retinal function more peripherally over the natural course of retinopathy. METHODS: Both eyes of 16 T2D patients (65.0 ± 10.1, 10 females), 10 with baseline DMO, were followed for up longitudinally for 27 months providing 94 data sets. Vasculopathy was assessed by fundus photography. Retinopathy was graded using to Early Treatment of Diabetic Retinopathy Study (ETDRS) guidelines. Posterior-pole OCT quantified a 64-region/eye thickness grid. Retinal function was measured with 10–2 Matrix perimetry, and the FDA-cleared OFA. Two multifocal pupillographic objective perimetry (mfPOP) variants presented 44 stimuli/eye within either the central 30° or 60° of the visual field, providing sensitivities and delays for each test-region. OCT, Matrix and 30° OFA data were mapped to a common 44 region/eye grid allowing change over time to be compared at the same retinal regions. RESULTS: In eyes that presented with DMO at baseline, mean retinal thickness reduced from 237 ± 25 μm to 234.2 ± 26.7 μm, while the initially non-DMO eyes significantly increased their mean thickness from 250.7 ± 24.4 μm to 255.7 ± 20.6 μm (both p<0.05). Eyes that reduced in retinal thickness over time recovered to more normal OFA sensitivities and delays (all p<0.021). Matrix perimetry quantified fewer regions that changed significantly over the 27 months, mostly presenting in the central 8 degrees. CONCLUSIONS: Changes in retinal function measured by OFA possibly offer greater power to monitor DMO over time than Matrix perimetry data. |
format | Online Article Text |
id | pubmed-10270604 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-102706042023-06-16 Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema Sabeti, Faran Rai, Bhim B. van Kleef, Josh P. Rohan, Emilie M. F. Carle, Corinne F. Barry, Richard C. Essex, Rohan W. Nolan, Christopher J. Maddess, Ted PLoS One Research Article PURPOSE: Retinal function beyond foveal vision is not routinely examined in the clinical screening and management of diabetic retinopathy although growing evidence suggests it may precede structural changes. In this study we compare optical coherence tomography (OCT) based macular structure with function measured objectively with the ObjectiveFIELD Analyzer (OFA), and with Matrix perimetry. We did that longitudinally in Type 2 diabetes (T2D) patients with mild Diabetic Macular Oedema (DMO) with good vision and a similar number of T2D patients without DMO, to evaluate changes in retinal function more peripherally over the natural course of retinopathy. METHODS: Both eyes of 16 T2D patients (65.0 ± 10.1, 10 females), 10 with baseline DMO, were followed for up longitudinally for 27 months providing 94 data sets. Vasculopathy was assessed by fundus photography. Retinopathy was graded using to Early Treatment of Diabetic Retinopathy Study (ETDRS) guidelines. Posterior-pole OCT quantified a 64-region/eye thickness grid. Retinal function was measured with 10–2 Matrix perimetry, and the FDA-cleared OFA. Two multifocal pupillographic objective perimetry (mfPOP) variants presented 44 stimuli/eye within either the central 30° or 60° of the visual field, providing sensitivities and delays for each test-region. OCT, Matrix and 30° OFA data were mapped to a common 44 region/eye grid allowing change over time to be compared at the same retinal regions. RESULTS: In eyes that presented with DMO at baseline, mean retinal thickness reduced from 237 ± 25 μm to 234.2 ± 26.7 μm, while the initially non-DMO eyes significantly increased their mean thickness from 250.7 ± 24.4 μm to 255.7 ± 20.6 μm (both p<0.05). Eyes that reduced in retinal thickness over time recovered to more normal OFA sensitivities and delays (all p<0.021). Matrix perimetry quantified fewer regions that changed significantly over the 27 months, mostly presenting in the central 8 degrees. CONCLUSIONS: Changes in retinal function measured by OFA possibly offer greater power to monitor DMO over time than Matrix perimetry data. Public Library of Science 2023-06-15 /pmc/articles/PMC10270604/ /pubmed/37319294 http://dx.doi.org/10.1371/journal.pone.0287319 Text en © 2023 Sabeti et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Sabeti, Faran Rai, Bhim B. van Kleef, Josh P. Rohan, Emilie M. F. Carle, Corinne F. Barry, Richard C. Essex, Rohan W. Nolan, Christopher J. Maddess, Ted Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema |
title | Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema |
title_full | Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema |
title_fullStr | Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema |
title_full_unstemmed | Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema |
title_short | Objective perimetry identifies regional functional progression and recovery in mild Diabetic Macular Oedema |
title_sort | objective perimetry identifies regional functional progression and recovery in mild diabetic macular oedema |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270604/ https://www.ncbi.nlm.nih.gov/pubmed/37319294 http://dx.doi.org/10.1371/journal.pone.0287319 |
work_keys_str_mv | AT sabetifaran objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema AT raibhimb objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema AT vankleefjoshp objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema AT rohanemiliemf objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema AT carlecorinnef objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema AT barryrichardc objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema AT essexrohanw objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema AT nolanchristopherj objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema AT maddessted objectiveperimetryidentifiesregionalfunctionalprogressionandrecoveryinmilddiabeticmacularoedema |